Title: FDA Approves Tapentadol for Relief of Moderate to Severe Acute Pain
|
|
To print: Select File and then Print from your browser's menu Title: FDA Approves Tapentadol for Relief of Moderate to Severe Acute Pain |
|
"FDA Approves Tapentadol for Relief of Moderate to Severe Acute Pain" NEW YORK -- November 21, 2008 -- The US Food and Drug Administration (FDA) has approved tapentadol immediate-release tablets for the relief of moderate to severe acute pain in adults aged 18 years or older. The approval was based on data from multiple phase 3 trials involving more than 2,100 patients. The studies showed that tapentadol provided significant relief of moderate to severe acute pain when compared with placebo. The medicine was also generally well tolerated. The studies were conducted in different patient groups, including those who had a bunionectomy, those with pain from end-stage joint disease, and in patients with low back pain or pain from osteoarthritis of the hip or knee. SOURCE: Johnson & Johnson |
|
Copyright © 2009 P\S\L Consulting Group Inc. All rights reserved. Republication or redistribution of P\S\L content is expressly prohibited without the prior written consent of P\S\L. P\S\L shall not be liable for any errors, omissions or delays in this content or any other content on its sites, newsletters or other publications, nor for any decisions or actions taken in reliance on such content. Go back This site is maintained by webmaster@pslgroup.com Please contact us with any comments, problems or bugs. All contents Copyright (c) 2009 P\S\L Consulting Group Inc. All rights reserved. |